We are determined to help as many people as possible
in a way that is rigorous and collaborative.
Our approach to scientific innovation
From advancing our investigational COMP360 psilocybin therapy for treatment-resistant depression, to building new care models, we will work with all parts of the healthcare system to develop scalable, evidence-based innovation to improve mental health care outcomes in all parts of our society.
Our commitment to Open Science
We are fully committed to Open Science. We will publish the results from all our trials and we support the publication of all results from independent studies that use our proprietary formulation of synthetic psilocybin, COMP360. Read more about our approach here